The significant effects of Raf protein kinases on cellular activities, together with high prevalence of mutation in melanoma, make Raf an attractive biological target for treatment of human melanoma disease (Ammar et al. 2018; El-Damasy et al. 2020). This evidence concerns the gene WEE1 and melanoma.